首页> 外文期刊>Research Journal of Pharmaceutical Sciences >Development and Optimization of Bilayer Floating Tablets of Glipizide
【24h】

Development and Optimization of Bilayer Floating Tablets of Glipizide

机译:格列吡嗪双层浮片的研制与优化

获取原文
           

摘要

Present work was an attempt for the development of FDDS with sustained-release of Glipizide using HPMC K-grade and Xanthan gum. The formulations showed promising sustained-release floating matrix tablets of Glipizide. Being obvious, HPMC K15M shown better retardation as compare to HPMC K 4M due to higher viscosity grade. High concentrations of higher viscosity-grade polymers induced the creation of stronger viscous-gel, which retarded the water penetration rate in the tablet-matrix, which might resulted in the extended release of drug. Polymer to drug ratio 2:1 shown better retardation due to higher concentration of polymers, while polymer to drug ratio 1:1 was unable to retard the release for 12hrs. When HPMC K15M and HPMC K4M used in ratio of 9:1 with xanthan gum, they shown more retardation and less than 75 % drug released in 12hrs, but when these polymers used in ratio 1:1 with xanthan gum shown better control over release pattern of the drug.
机译:目前的工作是尝试使用HPMC K级和黄原胶开发缓释格列吡嗪的FDDS。制剂显示格列吡嗪有希望的缓释漂浮基质片剂。很明显,由于粘度等级较高,HPMC K15M与HPMC K 4M相比显示出更好的延迟。高浓度的高粘度等级聚合物会诱导产生更强的粘性凝胶,从而阻碍片剂基质中的水渗透速率,从而可能导致药物的延长释放。聚合物与药物的比例为2:1,由于聚合物的浓度较高,因此显示出更好的阻滞作用,而聚合物与药物的比例为1:1,则无法在12小时内阻止释放。当HPMC K15M和HPMC K4M与黄原胶的比例为9:1时,它们显示出更大的阻滞性,并且在12小时内释放的药物少于75%,但是当这些聚合物与黄原胶的比例为1:1时,则显示出对释放模式的更好控制的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号